Document is current
Any future updates will be listed below
-
Authors
Wohlschlager, Therese https://orcid.org/0000-0001-9359-6744
Scheffler, Kai
Forstenlehner, Ines C.
Skala, Wolfgang
Senn, Stefan
Damoc, Eugen
Holzmann, Johann
Huber, Christian G. https://orcid.org/0000-0001-8358-1880
- License Information
-
More Information
Article History
Received: 2 May 2017
Accepted: 30 March 2018
First Online: 30 April 2018
Competing interests
: The authors declare the following competing financial interest(s): J.H. and I.C.F. are employees of Sandoz GmbH, K.S. and E.D. are employees of Thermo Fisher Scientific GmbH, which provide financial support for the Christian Doppler Laboratory for Innovative Tools for Biosimilar Characterization. The salary of T.W., W.S. and S.S. is fully funded, C.G.H.’s salary is partly funded by the Christian Doppler Laboratory for Biosimilar Characterization. Sandoz has obtained EMA and FDA approval for a biosimilar of Enbrel®. The authors declare no other competing financial interest.
